Skip to main content

Table 8 The relationship between the combined expression of BCL-2 and BAD in breast cancer cells and the relative inhibition ratio of 4 kinds of anticancer drugs

From: Expression of the apoptosis-related genes BCL-2 and BAD in human breast carcinoma and their associated relationship with chemosensitivity

Drugs

BCL-2(+)BAD(-)

BCL-2(+)BAD(+)

BCL-2(-)BAD(+)

BCL-2(-)BAD(-)

 

(n= 8)

(n= 5)

(n= 6)

(n= 1)

EADM

25.93 ± 3.05

33.47 ± 4.65

40.16 ± 5.20

37.72

5-Fu

24.18 ± 4.18

30.38 ± 4.81

37.86 ± 2.80

35.11

NVB

26.06 ± 7.43

36.62 ± 2.78

42.50 ± 2.63

38.88

DDP

23.01 ± 4.14

26.01 ± 4.73

31.90 ± 6.81

28.52